Skip to main content

Table 3 Comparison of intragroup mean visual acuity, mean central macular thickness and mean intraocular pressure values ​​after 3 anti-VEGF (3 months) and 6 anti-VEGF post or DEX 3 months (6 months)

From: Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema

 

AFL + AFL

RAN + RAN

AFL + DEX

RAN + DEX

Visual Acuity (LogMAR) after 3 anti-VEGF (3rd month)

0.59 ± 0.26

0.64 ± 0.32

0.8 ± 0.4

0.85 ± 0.43

6 Anti-VEGF or DEX 3rd month Average Visual Acuity (LogMAR) (6th month)

0.49 ± 0.22

0.57 ± 0.38

0.62 ± 0.38

0.80 ± 0.43

P value 3rd month*6th month

Visual Acuity (LogMAR)

0.132

0.284

0.064

0.704

Central Macular Thickness (µm) (3rd month) after 3 anti-VEGF

403.6 ± 70.4

411.5 ± 84

413.6 ± 88.1

418.1 ± 88

6 Post-anti-VEGF or DEX 3rd month Central Macular Thickness (µm) (6th month)

291.6 ± 54.4

293.1 ± 79.5

320 ± 103.8

332.5 ± 96.8

P value 3rd month*6th month Central Macular Thickness (µm)

0.000

0.000

0.001

0.000

Intraocular Pressure (mmHg) (3rd month) after 3 anti-VEGF

15.3 ± 2.7

15.4 ± 2.9

14.7 ± 2.9

16.2 ± 3.2

6 Post-anti-VEGF or DEX 3rd month Intraocular Pressure (mmHg) (6th month)

15.9 ± 3.5

15.59 ± 4

15.9 ± 3

18.1 ± 3.8

P value 3rd month*6th month Intraocular Pressure (mmHg)

0.542

0.834

0.013

0.027